~~<i id='C9F524FBCF'><strike id='C9F524FBCF'><tt id='C9F524FBCF'><pre id='C9F524FBCF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

Wikipedia

author：Wikipedia 2025-10-02 21:07:07 - browse：73

The Food and Drug Administration said on Friday that it has some safety concerns about an experimental CRISPR-based treatment for sickle cell disease, citing the methods used by its makers to evaluate the risk of inadvertently making unwanted changes to patients’ DNA.

None of the concerns raised by the FDA on Friday, however, suggest the agency is reluctant to approve the treatment, called exa-cel, which is being developed by Vertex Pharmaceuticals and CRISPR Therapeutics.

Exa-cel, given as a one-time infusion, uses CRISPR genome-editing technology to patch up the genetic faults at the root of sickle cell disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Unique patient identifier: Experts argue the benefits, pitfalls

knowledge

Wikipedia

entertainment

focus

knowledge

leisure time

Sen.JohnThuneisoneofagroupoflawmakersthatisworkingon340Breformlegislation.BRENDANSMIALOWSKI/AFPviaGe

WSS

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Physician assistants need a new name. Here's what it should be

JPM pitch from hospitals? Revenue streams outside of patient care

A preacher's new calling: Diversifying neuroscience research

Allen Institute goes after foundational questions, CEO Costa says

Gene therapy for Afghan refugees’ infant will be fully covered

knowledge

Wikipedia

knowledge

At least 13 dead in Texas as scorching temps continue

Cano Health’s bankruptcy is a warning for Medicare Advantage

DIEP, the 'gold standard' of breast reconstruction, is under threat

Does Paxlovid work in people vaccinated against Covid

Anesthesiologist group: stop taking Ozempic before surgery

JPM pitch from hospitals? Revenue streams outside of patient care

United colonoscopy coverage change 'may cost lives,' doctors say

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Allen Institute goes after foundational questions, CEO Costa says

Wikipedia

Texas Medical Board asked to define abortion emergency exception

Medicare Advantage overpayments discussion gets experts fired up

What’s missing from the debate over nursing home staff minimums

Stories you might have missed in 2023: health, science, medicine

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Global cancer cases to surge 77% by 2050, WHO report says

entertainment

focus

knowledge

leisure time